Using a fragment-based approach to develop inhibitors of coenzyme A biosynthesis in Mycobacterium tuberculosis, the bacterium that causes tuberculosis

点击翻译按钮获取中文摘要

The metabolism of vitamin B5 by pathogenic microorganisms has been recognised as an attractive target for developing drugs to combat various infectious diseases. The aim of the proposed work is to develop inhibitors of vitamin B5 metabolism in the bacterium that causes tuberculosis, using a powerful, multidisciplinary approach known as “fragment-based drug discovery”. This work is likely to yield potent inhibitors of the target bacterium, which could ultimately be used to treat tuberculosis.